Skip to main navigation menu Skip to main content Skip to site footer


Vol. 145 No. 0304 (2015)


  • F. J. Ten Cate
Cite this as:
Swiss Med Wkly. 2015;145:w14069


  1. Main ML, Ryan AC, Davis TE, Albano MP, Kusnetzky LL, Hibberd M. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent (multicenter registry results in 4,300,966 consecutive patients). Am J Cardiol. 2008;102:1742–6.
  2. Piscaglia F, Nolsøe C, Dietrich CF, Cosgrove DO, Gilja OH, Bachmann, Nielsen M, et al. The EFSUMB guidelines and recommendations on the clinical practice of contrast enhanced ultrasound (CEUS): update 2011 on non-hepatic applications. Ultraschall Med. 2012;33:33–59.
  3. Schinkel AF, Krueger CG, Tellez A, Granada JF, Reed JD, Hall A, et al. Contrast-enhanced ultrasound for imaging vasa vasorum: comparison with histopathology in a swine model of atherosclerosis. Eur J Echocardiogr. 2010;11:659–64.
  4. Staub D, Patel MB, Tibrewala A, Ludden D, Johnson M, Espinosa P, et al. Vasa vasorum and plaque neovascularization on contrast-enhanced carotid ultrasound imaging correlates with cardiovascular disease and past cardiovascular events. Stroke. 2010;41:41–7.
  5. Ten Kate GL, vanden Oord SCh, Sijbrands EJG, vanderLugt A, deJong N, Bosch JG, et al. J Vasc Surg. 2013;15:539–46.
  6. Kaspar M, Partovi S, Aschwanden M, Imfeld S, Baldi T, Uthoff H, Staub D. Assessment of microcirculation by contrast-enhanced ultrasound: a new approach in vascular medicine. Swiss Med Wkly. 2015;145:w14047.